The Green Rush 
Enveric Biosciences and MagicMed
by Nick Opich on July 8, 2021 in podcast
Podcast: Play in new window | Download
Podcast: Play in new window | Download
David Johnson, Chairman and CEO of Enveric Biosciences, a biotechnology company developing cannabinoid medicines to treat cancer and who last joined the Green Rush in March, and Dr. Joseph Tucker, CEO of MagicMed, a psychedelics company focused on creating a library of novel psychedelic molecules to treat a variety of indications are this week’s special guests on The Green Rush.
At the end of May, Enveric and MagicMed announced they had entered into a definitive merger agreement that will combine the research and discovery elements of the two companies to study how psychedelics and cannabinoids can benefit patients’ bodies and minds.
Anne and Nick sat down with David and Joseph to discuss the transaction, including how the deal came together, how the deal will benefit both patients and investors and the potential these new generations of medicines hold for patients suffering from a variety of indications. They also touch on some of the biggest challenges facing these industries and what they hope to accomplish in the near and long-term
So don’t sit back, lean forward and enjoy our conversation with David Johnson and Dr. Joseph Tucker.
Links and mentions in the show
Links to the guest’s company and social media accounts
- David Johnson’s LinkedIn: https://www.linkedin.com/in/david-johnson-235b0224/
- MagicMed LinkedIn: https://www.linkedin.cn/company/magicmedind
Show Credits:
This episode was hosted by Anne Donohoe and Nick Opich of KCSA Strategic Communications.
Special thanks to our Program Director Shea Gunther.
You can learn more about how KCSA Cannabis can help your cannabiz by visiting www.kcsa-cannabis.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels:
Twitter: @The_GreenRush
Instagram: @thegreenrush_podcast
LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/
Facebook: https://www.facebook.com/TheGreenRushPodcast/
YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true
More Episodes
Frank Perullo, Co-Founder & Strategic Advisor at Ascend Wellness Holdings
Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Kris Kane and Anne Donohoe return for a new episode with special guest Frank Perullo, Co-Founder and Strategic Advisor at Ascend Wellness Holdings ($AAWH). Frank joins us this week […]
Nathan Bryson, PhD, Chief Scientific Officer of Reunion Neuroscience
Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Lewis Goldberg and Anne Donohoe are back for a new episode with special guest Nathan Bryson, PhD, Chief Scientific Officer of Reunion Neuroscience. Nathan joins us this week to […]
Len May, CEO and Co-Founder of Endocanna Health
Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Anne Donohoe and Phil Carlson return for a new episode with special guest Len May, CEO and Co-Founder of Endocanna Health. Len joins us this week to share how […]
Adam Smith, Founder of Alliance for Sensible Markets
Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Anne Donohoe and Kris Krane are back for a new episode with special guest Adam Smith, Founder of Alliance for Sensible Markets. Adam joined us this week to talk […]
